Market Forecast Reports: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Market Forecast Reports.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 7, 2025

Dec. 7, 2025

URS Invests in Yellow Visa, acquiring 40% Stake to Accelerate AI-Driven Immigration Automation

EIN Presswire

Dec. 7, 2025

Grouse Railing Launches Premium Frameless Glass Railings for Modern Interior Design

EIN Presswire

Dec. 7, 2025

COGNNA announces a $9.2M Series A led by Impact46 with participation from BNVTCapital, VisionVentures, and TaliVentures.

EIN Presswire

Dec. 7, 2025

Selling Online Challenge With Russell Brunson Announces December 9–11, 2025 Live Virtual Training

EIN Presswire

Dec. 7, 2025

Smart Building Market Poised to Surpass $247.17 Billion by 2032 | Growing at 12.3% CAGR

EIN Presswire

Dec. 7, 2025

Satellite Internet Market Forecast to Cross USD 18.59 Billion by 2030 | Strong 20.4% CAGR

EIN Presswire

Dec. 7, 2025

USD 9.92 Billion Growth Expected in Europe Commercial Refrigeration Market | UK to Grow at 3.3% CAGR | AMR

EIN Presswire

Dec. 7, 2025

India Costume Jewelry Market has the Potential to Cross $2.12 Billion During 2019-2027

EIN Presswire

Dec. 7, 2025

Inferenz and Caregence Announce Strategic Merger to Redefine AI Innovation in Healthcare

EIN Presswire

$At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis$

Dec. 7, 2025

At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

GlobeNewswire

Dec. 7, 2025

ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025

GlobeNewswire

Dec. 7, 2025

Les forages recoupent une large zone minéralisée dans un nouveau secteur bien en dehors des ressources

GlobeNewswire

Dec. 7, 2025

Former National Security Analyst Signals a Warning in Recent Presentation: “Most Americans are completely uninformed about China’s ambition and power.”

GlobeNewswire

Dec. 7, 2025

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

GlobeNewswire

Dec. 7, 2025

MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire

Dec. 7, 2025

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET

GlobeNewswire

Dec. 7, 2025

Kessler Topaz Meltzer & Check, LLP Reminds StubHub Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

GlobeNewswire

Dec. 7, 2025

Nayax Considering an Offering of Notes and Warrants in Israel

GlobeNewswire

Dec. 7, 2025

Real Estate Expert Kerry Ramage of Melbourne, FL, Breaks Down Home Sale Strategy for HelloNation

GlobeNewswire

Dec. 7, 2025

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

GlobeNewswire